Immunohistochemical staining of Insulin  of human FFPE tissue followed by incubation with HRP labeled secondary and development with DAB substrate.

Insulin [K36aC10] Antibody (cGMP).

$ 135.00$ 405.00
Please Select Product Options Below To View The Catalog Number.

Species: Human
Tested Applications: IHC [IVD]
Available Conjugates:
Isotype: Mouse IgG1

Product NumberDescriptionPrice
QIVD296-0.1ml Size: 0.1 ml, Format: Concentrate $ 135.00
QIVD296-0.5ml Size: 0.5 ml, Format: Concentrate $ 245.00
QIVD296-1ml Size: 1 ml, Format: Concentrate $ 405.00
Shipping Information
In Stock
Flat Rate Shipping Anywhere in the US: $45
Datasheets and Documentation
Product Datasheet
Certificate of Analysis and Tags (Coming Soon)
Lot Number:

Expiration Date:

Concentration (Write Lyophilized if Lyophilized):

Reconsitution Instructions (Leave Blank if Liquid):

Manufacture Date:


Bioactivity (test results eg. IU/ml):

SKU: QIVD296-0.1ml
Insulin General Information
Alternate Names
Molecular Weight
12 kDa
Chromosomal Location
p15.5 [chr: 11] [chr_start: 2159779] [chr_end: 2161341] [strand: -1]
Curated Database and Bioinformatic Data
Gene SymbolINS
Entrez Gene ID3630
RefSeq Protein Accession(s)NP_001172027; NP_001172026; NP_000198; NP_001278826
RefSeq mRNA Accession(s); NM_001291897; NM_001185097; NM_000207; NM_001185098
RefSeq Genomic Accession(s)NG_007114; NC_000011; NG_050578
UniProt ID(s)P01308
PharmGKB ID(s)PA201
KEGG Gene ID(s)hsa:3630
Associated Diseases (KEGG IDs)Hyperproinsulinemia (HPRI) [MIM:616214]: An autosomal dominant condition characterized by elevated levels of serum proinsulin-like material. {ECO:0000269|PubMed:1601997, ECO:0000269|PubMed:2196279, ECO:0000269|PubMed:3470784, ECO:0000269|PubMed:4019786}. The disease is caused by mutations affecting the gene represented in this entry.; Diabetes mellitus, insulin-dependent, 2 (IDDM2) [MIM:125852]: A multifactorial disorder of glucose homeostasis that is characterized by susceptibility to ketoacidosis in the absence of insulin therapy. Clinical features are polydipsia, polyphagia and polyuria which result from hyperglycemia-induced osmotic diuresis and secondary thirst. These derangements result in long-term complications that affect the eyes, kidneys, nerves, and blood vessels. {ECO:0000269|PubMed:18192540}. The disease is caused by mutations affecting the gene represented in this entry.; Diabetes mellitus, permanent neonatal (PNDM) [MIM:606176]: A rare form of diabetes distinct from childhood-onset autoimmune diabetes mellitus type 1. It is characterized by insulin-requiring hyperglycemia that is diagnosed within the first months of life. Permanent neonatal diabetes requires lifelong therapy. {ECO:0000269|PubMed:17855560, ECO:0000269|PubMed:18162506}. The disease is caused by mutations affecting the gene represented in this entry.; Maturity-onset diabetes of the young 10 (MODY10) [MIM:613370]: A form of diabetes that is characterized by an autosomal dominant mode of inheritance, onset in childhood or early adulthood (usually before 25 years of age), a primary defect in insulin secretion and frequent insulin-independence at the beginning of the disease. {ECO:0000269|PubMed:18162506, ECO:0000269|PubMed:18192540, ECO:0000269|PubMed:20226046, ECO:0000269|PubMed:25423173}. The disease is caused by mutations affecting the gene represented in this entry.
General Description of Insulin .
This antibody recognizes purified insulin from the pancreas of human, as well as proinsulin from human.

Antibody (Suitable for clinical applications)

Sample Type: FFPE Patient Samples.
Tested Applications: IHC. Approved for In Vitro Diagnostic Procedures on FFPE tissues. For tissue collection recommendations, please see datasheet sent with product.
Application Notes
Specification Recommendation
Recommended Dilution (Conc) 1:25-1:50
Pretreatment No Pretreatment Required
Incubation Parameters 30 min at Room Temperature

Prior to use, inspect vial for the presence of any precipitate or other unusual physical properties. These can indicate that the antibody has degraded and is no longer suitable for patient samples. Please run positive and negative controls simultaneously with all patient samples to account and control for errors in laboratory procedure. Use of methods or materials not recommended by enQuire Bio including change to dilution range and detection system should be routinely validated by the user.

Clonality: Monoclonal
Anti-Insulin Antibody Clone: K36aC10
Host and Isotype: Mouse IgG1
Recommended Positive Control Sample: Pancreas
Cellular Localization of Antibody K36aC10 Staining: Cytoplasmic
Buffer and Stabilizer: PBS with 1% BSA and 0.05% NaN3
Antibody Concentration: Lot specific. Plese contact tech support for data.
Immunogen: Human insulin.
Storage Conditions: This antibody should be stored refrigerated (2-8°C). This product should not be used past the expiration date printed on the vial.

Insulin Information for Pathologists

Limitations and Warranty

This antibody is manufactured in accordance with clinical good manufacturing practices in an ISO13485:2016 certified production facility. It is intended for multiple uses including in vitro diagnostic use and research use only applications. Please see vial label for expiration date. We strive to always deliver antibodies with a shelf life of at least two years.

There are no reviews yet.

Be the first to review “Insulin [K36aC10] Antibody (cGMP).”

Your email address will not be published. Required fields are marked *

Share a Protocol (View Reviewed Protocols Below)

Protocol Title




  protocol submission gif
enQuire Bio, LLC   8420 S Continental Divide Rd, #202   Littleton, CO 80127
Chat: See lower right corner. | | Fax: 1-720-897-3730
Customer Service Available M-F 8AM-6PM MST or 24/7 Via Email

Insulin [K36aC10] Antibody (cGMP).